Olatoyosi Odenike to Chemotherapy-Induced Febrile Neutropenia
This is a "connection" page, showing publications Olatoyosi Odenike has written about Chemotherapy-Induced Febrile Neutropenia.
Connection Strength
0.090
-
All-Oral Treatment of Newly Diagnosed Acute Myeloid Leukemia. N Engl J Med. 2026 Jun 04; 394(21):2107-2116.
Score: 0.060
-
An open-label phase 2 study of glycogen synthase kinase-3 inhibitor LY2090314 in patients with acute leukemia. Leuk Lymphoma. 2016 08; 57(8):1800-6.
Score: 0.029